We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Spectral Announces Fourth Quarter and Fiscal 2013 Results

News   Apr 01, 2014

 
Spectral Announces Fourth Quarter and Fiscal 2013 Results
 
 
 

RELATED ARTICLES

Blood Gene Expression Markers Predictive of Pain

News

A breakthrough test to measure pain in patients could help stem the tide of the opioid crisis in Indiana, and throughout the rest of the nation.

READ MORE

Micro-CT Captures Lung Cancer Biomarkers

News

Micro-computed tomography correlates with endpoint histology and was able to detect pre-malignant tumours in mice bearing lung lesions.

READ MORE

Antidepressant Based on Ketamine Gets Backing from FDA Advisory Group

News

A form of the hallucinogenic party drug ketamine has cleared one of the final hurdles toward clinical use as an antidepressant. During a meeting at the US Food and Drug Administration (FDA) in Silver Spring, Maryland, an independent advisory panel voted 14-2 in favor of recommending a compound known as esketamine for use in treating depression.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE